首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1495947

顱內動脈瘤市場 – 2024 年至 2029 年預測

Intracranial Aneurysm Market - Forecasts from 2024 to 2029

出版日期: 2024年03月20日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

顱內動脈瘤市場預計將以 8.41% 的複合年成長率成長，從 2022 年的 14.11 億美元成長到 2029 年的 24.84 億美元。

腦動脈瘤（也稱為腦動脈瘤或顱內動脈瘤）是一種氣球狀動脈瘤，由大腦動脈壁的薄弱點發展而來。蛛網膜下腔出血 (SAH) 是指大腦周圍出血，當動脈變得「水泡狀」增大、變細並突然破裂時，就會發生這種情況。

這種出血可能導致中風、失去知覺，甚至死亡。動脈瘤的大小僅為約 1/8 英吋至 1 英吋。巨大動脈瘤很難治療，如果大於 1 英寸，則會帶來特別嚴重的風險。

顱內動脈瘤市場的成長機會

預計在預測期內，腦動脈瘤的盛行率將會增加，微創顱內動脈瘤手術預計將刺激顱內動脈瘤產業的發展。顱內動脈瘤導致腦動脈壁隆起。它可能會腫脹、擴散或非自然出血。

形成腦動脈瘤的危險因子包括吸菸、高血壓、血管創傷、遺傳脆弱性和血管損傷。腦動脈瘤的治療包括藥物治療、手術夾閉、血管內治療、以及單獨或與輔助器具組合的彈簧圈栓塞。

老年人口增加

顱內動脈瘤市場受到血管創傷和血壓過高患者數量不斷增加的推動。高血壓會顯著增加多種疾病的風險，包括腦動脈瘤。由於血壓過高和吸煙，很大一部分人面臨腦動脈瘤的風險。

根據 NCBI 的調查結果，老年人中未破裂腦動脈瘤的盛行率正在迅速增加，尤其是 70 歲以上的老年人。根據世界衛生組織2022年報告，到2050年，全球60歲及以上的人口將達到35億，而2019年這一數字為10億。

微創手術增加

如今，微創手術變得越來越普遍，因為它涉及的風險和創傷較小。較小的切口可減少術後不適並加快癒合速度，從而提高了這些治療方法的普及，並刺激了該領域的研究和開發。

幾個主要參與企業不斷投資於研發，以推出尖端的血管內卷取工具。醫師強烈建議的微創治療方法是血管內卷取，用於治療腦動脈瘤。在該手術中，將微導管放置在含有動脈瘤的腹股溝區域的動脈中。然後取下鉑線圈。鉑金彈簧圈有助於凝結動脈瘤並阻止血液流向大腦其他部位。

血管內卷取是推進部分

未來，血管內卷取預計將穩定成長。此手術的優點，例如容易進入脊椎骨系統、偏遠位置的大量動脈瘤以及比其他手術更快的恢復期，正在推動顱內動脈瘤市場的擴張。

此外，全球範圍內不斷增加的中風數量可能會導致血管破裂並導致腦動脈瘤，從而推動顱內動脈瘤市場的收益擴張。例如，世界中風組織 (WSO) 報告稱，2022 年將有大約 1,200 萬人 (12,224,551) 患有中風。

不斷上升的研發與技術突破

由於顱內動脈瘤治療的研發力度加大、醫療設施的改善、顱內動脈瘤診斷和治療新療法的技術進步、行業研發的成長以及日常醫療投資的增加，顱內動脈瘤行業正在蓬勃發展。預計在預測期內將經歷有利的成長機會。

例如，歌德大學神經病學和神經外科係正在對未破裂腦動脈瘤患者進行第 3 期臨床研究，研究乙醯水楊酸和積極血壓管理的組合。

擴大使用診斷影像技術來支持顱內動脈瘤市場

腦動脈瘤的診斷在很大程度上依賴三種影像方式：磁振造影血管造影術（MRA）、電腦斷層掃描（CTA）和動脈內數位減影血管造影術（IADSA）。 CTA 是一種非傳統血管攝影技術，在進行常規電腦斷層掃描的同時，透過靜脈注射顯影劑。

目前，識別顱內動脈瘤的黃金標準是IADSA。此外，醫生正在使用動脈內數位減影血管造影術來治療顱內動脈瘤患者。因此，推動顱內動脈瘤市場的原因之一是為顱內動脈瘤的治療提供優質影像的顯像模式。

預計將受到北美顱內動脈瘤市場的推動

由於其完善的醫療基礎設施、人口老化以及高血壓和中風的高發病率，預計北美將引領顱內動脈瘤市場，並佔據重要的收益佔有率。

此外，腦動脈瘤發生率的上升和對微創手術的需求正在推動該地區顱內動脈瘤市場的擴張。預計各個組織計劃的增加也將促進顱內動脈瘤市場的擴張。例如，蜜蜂基金會 (TBF) 致力於透過前沿研究提高人們對腦動脈瘤的認知並減少腦動脈瘤造成的死亡人數。

亞太地區預計將成為第二大成長市場

亞太地區顱內動脈瘤產業預計將成長。這是由於人口老化、生活方式壓力眾多、高血壓盛行率不斷上升、診斷品質提高以及患者負擔減輕。

由於上述所有變量，亞太地區的腦動脈瘤手術顯著增加。此外，中國、印度和日本等新興國家誘人的市場開拓前景可能有助於該地區顱內動脈瘤市場的擴張。例如，印度醫療旅遊的增加預計將提振市場，因為與美國等已開發國家相比，顱內手術的成本相對較低。

A brain aneurysm is a ballooning that develops from a weak spot in the wall of a blood artery in the brain (also known as a cerebral aneurysm or an intracranial aneurysm). A subarachnoid hemorrhage (SAH), which causes bleeding into the area around the brain, occurs when the artery develops a "blister-like" dilatation that can thin out and burst suddenly.

Such a hemorrhage may result in a stroke, unconsciousness, or even death. Aneurysms can be anything from a little 1/8 inch and about one inch in size. Giant aneurysms are difficult to cure and pose a particularly significant danger if they are greater than one inch.

Market growth opportunities for the intracranial aneurysm market

The prevalence of brain aneurysms is expected to increase over the forecast period, and minimally invasive intracranial aneurysm surgeries are expected to be used more frequently fueling the intracranial aneurysm industry. A cerebral artery's wall bulges due to an intracranial aneurysm. An unnatural inflating, widening, or bleb is the outcome.

Risk factors for the occurrence of a brain aneurysm include smoking, hypertension, blood vessel trauma, hereditary vulnerability, and blood vessel damage. Brain aneurysms may be treated with medical therapy, surgical clipping, endovascular therapy, or coiling alone or in combination with auxiliary devices.

Growing geriatric population

The intracranial aneurysm market is being driven by the rising number of patients who have blood vessel trauma and excessive blood pressure. Hypertension significantly raises the risk of several disorders, including brain aneurysms. A significant section of the population is in danger of developing brain aneurysms because of excessive blood pressure and smoking.

Unruptured brain aneurysm prevalence in senior people is rising quickly, especially in those who are 70 years or older, according to NCBI research findings. According to the WHO Report 2022, there will be 3.5 billion people in the globe who are 60 years of age or older by 2050, up from 1 billion in 2019.

Growth in the use of minimally invasive surgeries

Minimally invasive operations are becoming common nowadays due to their lower risk and trauma. Smaller incisions reduce postoperative discomfort and speed up healing, which encourages the widespread use of these treatments and spurs an increase in R&D in the area.

To introduce cutting-edge minimally invasive endovascular coiling tools, several important players are consistently investing in R&D. One of the less invasive treatments that is strongly advised by doctors is the endovascular coiling used to treat cerebral aneurysms. A microcatheter is placed during this surgery through the aneurysm-containing artery in the groyne region. After that, platinum coils are removed since they encourage aneurysm clotting and stop blood flow to other parts of the brain.

Endovascular coiling is a propelling sector

The future is expected to see steady growth for endovascular coiling. The benefits of this operation, including simple access to the vertebrobasilar system, numerous aneurysms in remote locations, and a quicker recovery period than with other procedures, are the reasons driving the intracranial aneurysm market expansion.

Additionally, there is a strong likelihood that the increasing number of strokes occurring globally would rupture blood vessels and cause cerebral aneurysms, which will encourage intracranial aneurysm market revenue growth. For instance, the World Stroke Organization (WSO) reported that in 2022, around 12 million (12,224,551) persons suffered from a stroke.

Growing research and development and technological breakthroughs

With the rise in research and development for the treatment of intracranial aneurysms, improved healthcare facilities, technological advancements in the diagnosis of intracranial aneurysms and the treatment with novel therapeutics, growing research and development in the industry as well as daily increases in healthcare investment, the intracranial aneurysm industry will experience lucrative growth opportunities in the forecast period.

For instance, Acetylsalicylic acid combined with aggressive blood pressure management is being studied in phase 3 clinical investigation at Goethe University's Department of Neurology and Neurosurgery in patients with unruptured cerebral aneurysms.

Increasing the use of imaging techniques to assist the intracranial aneurysm market

The diagnosis of cerebral aneurysms relies heavily on three imaging modalities, magnetic resonance angiography (MRA), computed tomography (CTA), and intra-arterial digital subtraction angiography (IADSA). CTA is a different vascular imaging technique that includes getting a conventional CT scan while receiving an intravenous contrast injection.

The gold standard for identifying intracranial aneurysms at the moment is IADSA. Additionally, medical practitioners use intra-arterial digital subtraction angiography to treat intracranial aneurysm patients. Therefore, one of the reasons propelling the intracranial aneurysm market is imaging modalities that offer superior pictures for the treatment of intracranial aneurysms.

The North American intracranial aneurysm market is projected to propel

North America is anticipated to lead the intracranial aneurysm market and account for a large revenue share due to its established healthcare infrastructure, ageing population, and high rates of hypertension and stroke.

Additionally, a rise in the incidence of cerebral aneurysms and a need for less invasive procedures are fueling intracranial aneurysm market expansion in the area. An increasing number of projects being carried out by various groups is also projected to encourage intracranial aneurysm market expansion. For instance, The Bee Foundation (TBF) is committed to raising awareness and lowering the number of fatalities brought on by brain aneurysms via cutting-edge studies.

Asia Pacific is anticipated to be the second-largest growing market

The Asia Pacific intracranial aneurysm industry is anticipated to grow. This is due to several causes, including an ageing population, numerous lifestyle stressors, an increase in the prevalence of hypertension, better diagnostic quality, and increased patient affordability.

The Asia Pacific region has seen a large increase in cerebral aneurysm surgeries as a result of all the aforementioned variables. Moreover, the expansion of the regional intracranial aneurysm market is likely aided by attractive development prospects in emerging nations like China, India, and Japan. For instance, rising medical tourism to India is anticipated to boost the market because of the comparatively inexpensive cost of intracranial surgery compared to other industrialized nations like the U.S.

Market Key Developments

In June 2023, researchers at the RIKEN Centre for Brain Science (CBS) in Japan identified a group of linked mutations that cause intracranial aneurysms weakened blood arteries in the brain that are prone to rupture at any time.
In September 2022, Vesalio announced that the NeVa VS has been approved by the Food and Drug Administration to treat cerebral vasospasm following aneurysmal rupture.
In June 2022, the first Numen coil embolization treatment and portfolio expansion by Rapid Medical were announced. Rapid Medical and MicroPort NeuroTech, a division of MicroPort Scientific Corporation, have an exclusive distribution arrangement.

Segmentation:

By Type

Surgical Clipping
Endovascular Coiling
Flow Diverters
Others

By Diagnosis Type

CT scan
MRI
Cerebral Angiography
Cerebrospinal Fluid (CSF) Analysis

By End-User

Hospitals
Clinics
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. INTRACRANIAL ANEURYSM MARKET, BY TYPE

5.1. Introduction
5.2. Surgical Clipping
- 5.2.1. Market Trends and Opportunities
- 5.2.2. Growth Prospects
- 5.2.3. Geographic Lucrativeness
5.3. Endovascular Coiling
- 5.3.1. Market Trends and Opportunities
- 5.3.2. Growth Prospects
- 5.3.3. Geographic Lucrativeness
5.4. Flow Diverters
- 5.4.1. Market Trends and Opportunities
- 5.4.2. Growth Prospects
- 5.4.3. Geographic Lucrativeness
5.5. Others
- 5.5.1. Market Trends and Opportunities
- 5.5.2. Growth Prospects
- 5.5.3. Geographic Lucrativeness

6. INTRACRANIAL ANEURYSM MARKET, BY DIAGNOSIS TYPE

6.1. Introduction
6.2. CT scan
- 6.2.1. Market Trends and Opportunities
- 6.2.2. Growth Prospects
- 6.2.3. Geographic Lucrativeness
6.3. MRI
- 6.3.1. Market Trends and Opportunities
- 6.3.2. Growth Prospects
- 6.3.3. Geographic Lucrativeness
6.4. Cerebral Angiography
- 6.4.1. Market Trends and Opportunities
- 6.4.2. Growth Prospects
- 6.4.3. Geographic Lucrativeness
6.5. Cerebrospinal Fluid (CSF) Analysis
- 6.5.1. Market Trends and Opportunities
- 6.5.2. Growth Prospects
- 6.5.3. Geographic Lucrativeness

7. INTRACRANIAL ANEURYSM MARKET, BY END-USER

7.1. Introduction
7.2. Hospitals
- 7.2.1. Market Trends and Opportunities
- 7.2.2. Growth Prospects
- 7.2.3. Geographic Lucrativeness
7.3. Clinics
- 7.3.1. Market Trends and Opportunities
- 7.3.2. Growth Prospects
- 7.3.3. Geographic Lucrativeness
7.4. Others
- 7.4.1. Market Trends and Opportunities
- 7.4.2. Growth Prospects
- 7.4.3. Geographic Lucrativeness

8. INTRACRANIAL ANEURYSM MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Type
- 8.2.2. By Diagnosis Type
- 8.2.3. By End Users
- 8.2.4. By Country
  - 8.2.4.1. United States
    - 8.2.4.1.1. Market Trends and Opportunities
    - 8.2.4.1.2. Growth Prospects
  - 8.2.4.2. Canada
    - 8.2.4.2.1. Market Trends and Opportunities
    - 8.2.4.2.2. Growth Prospects
  - 8.2.4.3. Mexico
    - 8.2.4.3.1. Market Trends and Opportunities
    - 8.2.4.3.2. Growth Prospects
8.3. South America
- 8.3.1. By Type
- 8.3.2. By Diagnosis Type
- 8.3.3. By End Users
- 8.3.4. By Country
  - 8.3.4.1. Brazil
    - 8.3.4.1.1. Market Trends and Opportunities
    - 8.3.4.1.2. Growth Prospects
  - 8.3.4.2. Argentina
    - 8.3.4.2.1. Market Trends and Opportunities
    - 8.3.4.2.2. Growth Prospects
  - 8.3.4.3. Others
    - 8.3.4.3.1. Market Trends and Opportunities
    - 8.3.4.3.2. Growth Prospects
8.4. Europe
- 8.4.1. By Type
- 8.4.2. By Diagnosis Type
- 8.4.3. By End Users
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
    - 8.4.4.1.1. Market Trends and Opportunities
    - 8.4.4.1.2. Growth Prospects
  - 8.4.4.2. Germany
    - 8.4.4.2.1. Market Trends and Opportunities
    - 8.4.4.2.2. Growth Prospects
  - 8.4.4.3. France
    - 8.4.4.3.1. Market Trends and Opportunities
    - 8.4.4.3.2. Growth Prospects
  - 8.4.4.4. Spain
    - 8.4.4.4.1. Market Trends and Opportunities
    - 8.4.4.4.2. Growth Prospects
  - 8.4.4.5. Others
    - 8.4.4.5.1. Market Trends and Opportunities
    - 8.4.4.5.2. Growth Prospects
8.5. Middle East and Africa
- 8.5.1. By Type
- 8.5.2. By Diagnosis Type
- 8.5.3. By End Users
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
    - 8.5.4.1.1. Market Trends and Opportunities
    - 8.5.4.1.2. Growth Prospects
  - 8.5.4.2. UAE
    - 8.5.4.2.1. Market Trends and Opportunities
    - 8.5.4.2.2. Growth Prospects
  - 8.5.4.3. Israel
    - 8.5.4.3.1. Market Trends and Opportunities
    - 8.5.4.3.2. Growth Prospects
  - 8.5.4.4. Others
    - 8.5.4.4.1. Market Trends and Opportunities
    - 8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
- 8.6.1. By Type
- 8.6.2. By Diagnosis Type
- 8.6.3. By End Users
- 8.6.4. By Country
  - 8.6.4.1. Japan
    - 8.6.4.1.1. Market Trends and Opportunities
    - 8.6.4.1.2. Growth Prospects
  - 8.6.4.2. China
    - 8.6.4.2.1. Market Trends and Opportunities
    - 8.6.4.2.2. Growth Prospects
  - 8.6.4.3. India
    - 8.6.4.3.1. Market Trends and Opportunities
    - 8.6.4.3.2. Growth Prospects
  - 8.6.4.4. South Korea
    - 8.6.4.4.1. Market Trends and Opportunities
    - 8.6.4.4.2. Growth Prospects
  - 8.6.4.5. Indonesia
    - 8.6.4.5.1. Market Trends and Opportunities
    - 8.6.4.5.2. Growth Prospects
  - 8.6.4.6. Thailand
    - 8.6.4.6.1. Market Trends and Opportunities
    - 8.6.4.6.2. Growth Prospects
  - 8.6.4.7. Others
    - 8.6.4.7.1. Market Trends and Opportunities
    - 8.6.4.7.2. Growth Prospects